Clinical outcome and safety of periodic infliximab therapy in children and adolescents with Crohn's disease.
Antonella
A
Diamanti
Bronislava
B
Papadatou
Daniela
D
Knafelz
Manuela
M
Gambarara
Francesca
F
Ferretti
Massimo
M
Castro
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003424:Crohn Disease / Q000628:therapy*; D006801:Humans; D000069285:Infliximab; D007263:Infusions, Parenteral; D012449:Safety; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000069285:Infliximab